BR100 Increased By (0.75%)
BR30 Increased By (1.08%)
KSE100 Increased By (0.82%)
KSE30 Increased By (0.89%)
AGHA 6.42 Increased By ▲ 0.04 (0.63%)
BECO 4.32 Decreased By ▼ -0.03 (-0.69%)
BML 62.90 Increased By ▲ 0.35 (0.56%)
BOP 31.50 Increased By ▲ 0.11 (0.35%)
CNERGY 11.89 Increased By ▲ 0.16 (1.36%)
CSIL 5.86 Decreased By ▼ -0.05 (-0.85%)
FCCL 62.30 Increased By ▲ 0.59 (0.96%)
FFL 14.86 Increased By ▲ 0.07 (0.47%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.36 Increased By ▲ 0.04 (0.63%)
KOSM 5.85 Decreased By ▼ -0.05 (-0.85%)
LOTCHEM 24.71 Increased By ▲ 0.02 (0.08%)
MLCF 106.30 Increased By ▲ 2.37 (2.28%)
NBP 174.59 Increased By ▲ 1.27 (0.73%)
NCPL 52.40 Increased By ▲ 0.57 (1.1%)
NPL 55.00 Increased By ▲ 0.97 (1.8%)
OGDC 320.61 Increased By ▲ 4.74 (1.5%)
PACE 9.34 Increased By ▲ 0.08 (0.86%)
PAEL 35.82 Increased By ▲ 0.24 (0.67%)
PIBTL 13.86 Increased By ▲ 0.20 (1.46%)
PPL 228.70 Increased By ▲ 2.63 (1.16%)
PRL 81.99 Increased By ▲ 1.71 (2.13%)
PTC 47.14 Increased By ▲ 0.50 (1.07%)
SSGC 24.00 Increased By ▲ 0.18 (0.76%)
TBL 9.26 Increased By ▲ 0.02 (0.22%)
TELE 7.54 Decreased By ▼ -0.01 (-0.13%)
TPL 25.00 Increased By ▲ 0.46 (1.87%)
TPLP 13.13 Increased By ▲ 0.14 (1.08%)
TREET 26.11 Increased By ▲ 0.13 (0.5%)
TRG 53.80 Increased By ▲ 0.47 (0.88%)
Markets

China stocks gain as country approves first CAR-T cell therapy

  • The yuan was quoted at 6.4807 per US dollar, 0% firmer than the previous close of 6.481.
Published Updated
By

SHANGHAI: China shares rose on Wednesday, with healthcare stocks leading the gains after the country approved its first CAR-T cell therapy, while investors cheered the Federal Reserve's assurance that the US central bank will not hasten to hike rates.

** At the midday break, the Shanghai Composite index was up 0.46% at 3,573.61 points, rising for the third consecutive day. China's blue-chip CSI300 index was up 0.77%.

** The financial sector sub-index climbed 0.13%, the consumer staples sector was down 1.24%, while the real estate index added 0.13%.

** Chinese H-shares listed in Hong Kong rose 1.43% to 10,619.02, while the Hang Seng Index was up 1.46% at 28,721.85.

** The smaller Shenzhen index was up 0.81%, the start-up board ChiNext Composite index advanced 1.63%, and Shanghai's tech-focused STAR50 index climbed 1.53%?.

** The largest percentage gainers in the main Shanghai Composite index were Liaoning SG Automotive Group Co Ltd, up 10.1%, followed by Anhui Jianghuai Automobile Group Corp Ltd , gaining 10.05%.

** Shanghai-listed shares of Shanghai Fosun Pharmaceutical Group Co Ltd rose as much as 3.4% after China approved the first CAR-T cell therapy in the country as a joint venture of Fosun Pharmaceutical had obtained the rights to sell the therapy in China.

** Leading the gains, the healthcare sub-index rose 1.11%.

** Lifting investors' risk appetite was Fed chief Jerome Powell's reassurance of the goal of a broad labour market recovery while he also said fear of inflation alone would not be enough to prompt rate rises.

** China's state planner said on Wednesday that it and the market regulator have recently sent teams to various areas to look into commodities prices and supplies and would learn about mid- and downstream companies' situations.

** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.74% while Japan's Nikkei index was up 0.02%.

** The yuan was quoted at 6.4807 per US dollar, 0% firmer than the previous close of 6.481.

Comments

Comments are closed for this article.